Antidepressant Treatment in Chronic Central Serous Chorioretinopathy: Case Series

Turkoglu C.

Journal of the College of Physicians and Surgeons Pakistan, cilt.35, sa.1, ss.54-56, 2025 (SCI-Expanded, Scopus) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 35 Sayı: 1
  • Basım Tarihi: 2025
  • Doi Numarası: 10.29271/jcpspcr.2025.54
  • Dergi Adı: Journal of the College of Physicians and Surgeons Pakistan
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CAB Abstracts, MEDLINE, Veterinary Science Database
  • Sayfa Sayıları: ss.54-56
  • Anahtar Kelimeler: Central serous chorioretinopathy, Choroid, Depression, Escitalopram, Visual acuity
  • Lokman Hekim Üniversitesi Adresli: Evet

Özet

The study investigated chronic central serous chorioretinopathy (CSCR) patients who were observed and treated between February 2023 and 2024. It is a prospective, observational case series. Three patients diagnosed with chronic CSCR, aged between 38 and 64 years, were included in the study. One (33.3%) of the patients was female and two (66.7%) were males. The patients were followed with Optical Coherence Tomography (OCT) and OCT angiography for 12 months under oral escitalopram 10 mg treatment. Following the treatment, both anatomical improvement and visual acuity increase were detected in all patients. In addition to the advantage of being noninvasive, oral escitalopram treatment appears to contribute quickly and effectively to anatomical and functional recovery.